
Alignment Healthcare (ALHC) Stock Forecast & Price Target
Alignment Healthcare (ALHC) Analyst Ratings
Bulls say
Alignment Healthcare Inc. is strategically positioned to capitalize on the anticipated stronger 2026 Medicare Advantage rate update, particularly as many managed care organizations reduce benefits, allowing Alignment to leverage its Stars funding advantage. The company’s integrated Medicare Advantage-Value-Based Care model is expected to facilitate long-term market share growth and robust revenue expansion. Additionally, the projected gross profit per member per month for year one to two cohorts is estimated to range from $90 to $150, with significant potential to increase to over $230 in years three to five, indicating a favorable financial trajectory and the possibility of enhanced membership growth and margin maturation.
Bears say
Alignment Healthcare Inc. has faced challenges with its value-based care (VBC) model, including data friction among various payors, which could hinder operational efficiency and affect financial performance. Although the company has successfully driven its Average Daily Kiss (ADK) lower in a high-utilization environment, it must navigate these inherent disadvantages to sustain its growth trajectory. Furthermore, despite prioritizing technological advancements and reporting positive EBITDA growth, Alignment Healthcare's valuation multiple remains positioned slightly above the long-term range for peer managed care organizations, suggesting potential concerns over future financial sustainability.
This aggregate rating is based on analysts' research of Alignment Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Alignment Healthcare (ALHC) Analyst Forecast & Price Prediction
Start investing in Alignment Healthcare (ALHC)
Order type
Buy in
Order amount
Est. shares
0 shares